Evidence map›Paper›PMID 36215287›Full record

ArticlePloS one2022

Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?

Danique M J Hellebrekers, Sandra A M van Abeelen, Coriene E Catsman, Sander M J van Kuijk, Annick M Laridon, Sylvia Klinkenberg, Jos G M Hendriksen, Johan S H Vles

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Danique M J HellebrekersCentre for Neurological Learning Disabilities, Kempenhaege, Heeze, The Netherlands.ORCID 0000-0003-3061-2502
Sandra A M van AbeelenCentre for Neurological Learning Disabilities, Kempenhaege, Heeze, The Netherlands.ORCID 0000-0003-3638-140X
Coriene E CatsmanDepartment of Neurology, Erasmus Medisch Centrum, Rotterdam, The Netherlands.
Sander M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands.
Annick M LaridonCentre for Neurological Learning Disabilities, Kempenhaege, Heeze, The Netherlands.
Sylvia KlinkenbergCentre for Neurological Learning Disabilities, Kempenhaege, Heeze, The Netherlands.
Jos G M HendriksenCentre for Neurological Learning Disabilities, Kempenhaege, Heeze, The Netherlands.
Johan S H VlesSchool for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLKempenhaeghe · NLMaastricht University Medical Centre · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of neurocognitive and behavioral problems are common features in various neurogenetic disorders. In Duchenne muscular dystrophy (DMD), these problems have been linked to mutations along the dystrophin gene affecting different brain dystrophin isoforms. However, comparable cognitive and behavioral problems have been found in Neurofibromatosis type 1 (NF1). This study aims to assess disorder specific differences in cognition and behavior between DMD and NF1. Retrospective data of 38 male patients with DMD were aged-matched with data of 38 male patients with NF1. Patients of both groups underwent neurocognitive assessment for regular clinical care. Intellectual abilities, sequential and simultaneous processing, verbal memory and sustained attention were evaluated. In addition, parents and teachers completed behavioral questionnaires. Males with DMD exhibited low intellectual abilities and sequential processing problems, but these outcomes not significantly differed from males with NF1. Simultaneous processing, verbal memory and sustained attention outcomes were equal for both groups. Outcomes of questionnaires displayed higher rates of aggressive behavior (13.2%) in DMD, whereas in NF1 higher rates of problems with thinking (15.8%), withdrawn (10.5%) and social behavior (10.5%) were noticed. In the neurogenetic disorders DMD and NF1, on average overlapping cognitive and behavioral problems are noticed, suggesting that these are not only caused by gene mutations resulting in a lack of one specific protein.

Indexed as

Muscular Dystrophy, DuchenneNeurofibromatosis 1AgedCognitionDystrophinHumansMaleProtein IsoformsRetrospective StudiesDystrophinProtein Isoforms

Identifiers

PMID36215287
PMCPMC9551631
OpenAlexW4304092362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.